EIN News February 1, 2023
Product innovations in the biopharmaceutical industry are the steering the course of Healthcare’s future, with several drugs receiving FDA approval in 2022
In the list of FDA approved drugs, Oncology medications led the pack by scoring 12 approvals, while Autoimmune therapies came second with 7 approvals”
— Dr. Purav Gandhi
AHMEDABAD, GUJARAT, INDIA, February 1, 2023 /EINPresswire.com/ — Healthark Insights has recently launched a research report titled “Top 10 Healthcare Innovations in 2022”, focused on capturing the top product innovations in the biopharmaceutical industry that were approved during the year 2022. Healthark Insights team tracked and identified 50 plus innovations that were approved and came to the market during the year 2022 that demonstrated the potential to be...
Today's Sponsors
Today's Sponsor